Evaluation of two commercially available rapid diagnostic tests for Lyme borreliosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 1, 2015, Pages 109-113

  Smit, P W ^a,b   Kurkela, S ^c,d   Kuusi, M ^b   Vapalahti, O ^c,d  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

BLOOD; BORRELIA BURGDORFERI; COMPARATIVE STUDY; DIAGNOSTIC TEST; EVALUATION STUDY; HUMAN; IMMUNOASSAY; IMMUNOLOGY; LYME DISEASE; PROCEDURES; SENSITIVITY AND SPECIFICITY; TIME;

BORRELIA BURGDORFERI; DIAGNOSTIC TESTS, ROUTINE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYME DISEASE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84938978070     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2217-5     Document Type: Article

References (12)

1. Stanek G, Wormser GP, Gray J, Strle F (2012) Lyme borreliosis. Lancet 379:461–473
2. Aguero-Rosenfeld M, Wang Q, Schwartz I, Wormser GP (2005) Diagnosis of Lyme borreliosis. Clin Microbiol Rev 18:484–509
3. Jaakola S, Lyytikäinen O, Rimhanen-Finne R et al (2013) Infectious diseases in Finland 2013. National Institute of Health and Welfare, Helsinki
4. Busson L, Reynders M, Van den Wijngaert S et al (2012) Evaluation of commercial screening tests and blot assays for the diagnosis of Lyme borreliosis. Diagn Microbiol Infect Dis 73:246–251
5. Lee SH, Vigliotti JS, Vigliotti VS, Jones W, Shearer DM (2014) Detection of borreliae in archived sera from patients with clinically suspect Lyme disease. Int J Mol Sci 15:4284–4298
6. Ang CW, Notermans DW, Hommes M, Simoons-Smit AM, Herremans T (2011) Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots. Eur J Clin Microbiol Infect Dis 30:1027–1032
7. Smit P, Mabey D, Changalucha J et al (2013) The trade-off between accuracy and accessibility of syphilis screening assays. PLoS One 8:e75327
8. Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(8–16):e1–e4
9. Mabey D, Peeling RW, Ustianowski A, Perkins MD (2004) Diagnostics for the developing world. Nat Rev Microbiol 2:231–240
10. Mabey DC, Sollis KA, Kelly HA et al (2012) Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilis. PLoS Med 9:e1001233
11. Hurly DS, Buhrer-Skinner M, Badman SG et al (2013) Field evaluation of the CRT and ACON chlamydia point-of-care tests in a tropical, low-resource setting. Sex Transm Infect 90:179–184
12. Herring AJ, Ballard RC, Pope V et al (2006) A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera. Sex Transm Infect 82 [Suppl 5]:v7–v12